173 related articles for article (PubMed ID: 35389487)
1. A Randomized Trial of ω-3 Fatty Acid Supplementation and Circulating Lipoprotein Subclasses in Healthy Older Adults.
Moosavi D; Vuckovic I; Kunz HE; Lanza IR
J Nutr; 2022 Jul; 152(7):1675-1689. PubMed ID: 35389487
[TBL] [Abstract][Full Text] [Related]
2. N-3 polyunsaturated fatty acids improve lipoprotein particle size and concentration in Japanese patients with type 2 diabetes and hypertriglyceridemia: a pilot study.
Ide K; Koshizaka M; Tokuyama H; Tokuyama T; Ishikawa T; Maezawa Y; Takemoto M; Yokote K
Lipids Health Dis; 2018 Mar; 17(1):51. PubMed ID: 29544483
[TBL] [Abstract][Full Text] [Related]
3. Changes in lipoprotein particle subclasses, standard lipids, and apolipoproteins after supplementation with n-3 or n-6 PUFAs in abdominal obesity: A randomized double-blind crossover study.
Grytten E; Laupsa-Borge J; Bohov P; Bjørndal B; Strand E; Skorve J; Nordrehaug JE; Berge RK; Rostrup E; Mellgren G; Dankel SN; Nygård OK
Clin Nutr; 2021 May; 40(5):2556-2575. PubMed ID: 33933722
[TBL] [Abstract][Full Text] [Related]
4. Distinct Influence of Omega-3 Fatty Acids on the Plasma Metabolome of Healthy Older Adults.
Xyda SE; Vuckovic I; Petterson XM; Dasari S; Lalia AZ; Parvizi M; Macura SI; Lanza IR
J Gerontol A Biol Sci Med Sci; 2020 Apr; 75(5):875-884. PubMed ID: 31168623
[TBL] [Abstract][Full Text] [Related]
5. Habitual Fish Consumption, n-3 Fatty Acids, and Nuclear Magnetic Resonance Lipoprotein Subfractions in Women.
Amigó N; Akinkuolie AO; Chiuve SE; Correig X; Cook NR; Mora S
J Am Heart Assoc; 2020 Mar; 9(5):e014963. PubMed ID: 32102617
[TBL] [Abstract][Full Text] [Related]
6. Docosahexaenoic acid supplementation improves fasting and postprandial lipid profiles in hypertriglyceridemic men.
Kelley DS; Siegel D; Vemuri M; Mackey BE
Am J Clin Nutr; 2007 Aug; 86(2):324-33. PubMed ID: 17684201
[TBL] [Abstract][Full Text] [Related]
7. The effect of n-3 fatty acids on plasma lipids and lipoproteins and blood pressure in patients with CRF.
Svensson M; Christensen JH; Sølling J; Schmidt EB
Am J Kidney Dis; 2004 Jul; 44(1):77-83. PubMed ID: 15211441
[TBL] [Abstract][Full Text] [Related]
8. N-3 fatty acid supplementation mediates lipid profile, including small dense LDL, when combined with statins: a randomized double blind placebo controlled trial.
Dogay Us G; Mushtaq S
Lipids Health Dis; 2022 Sep; 21(1):84. PubMed ID: 36050695
[TBL] [Abstract][Full Text] [Related]
9. Small supplements of N-3 fatty acids change serum low density lipoprotein composition by decreasing phospholid and apolipoprotein B concentrations in young adult women.
Sanchez-Muniz FJ; Bastida S; Viejo JM; Terpstra AH
Eur J Nutr; 1999 Feb; 38(1):20-7. PubMed ID: 10338684
[TBL] [Abstract][Full Text] [Related]
10. Omega 3 Improves Both apoB100-containing Lipoprotein Turnover and their Sphingolipid Profile in Hypertriglyceridemia.
Ferchaud-Roucher V; Zair Y; Aguesse A; Krempf M; Ouguerram K
J Clin Endocrinol Metab; 2020 Oct; 105(10):. PubMed ID: 32805740
[TBL] [Abstract][Full Text] [Related]
11. Substitution of dietary ω-6 polyunsaturated fatty acids for saturated fatty acids decreases LDL apolipoprotein B-100 production rate in men with dyslipidemia associated with insulin resistance: a randomized controlled trial.
Drouin-Chartier JP; Tremblay AJ; Lépine MC; Lemelin V; Lamarche B; Couture P
Am J Clin Nutr; 2018 Jan; 107(1):26-34. PubMed ID: 29381796
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of a Novel ω-3 Krill Oil Agent in Patients With Severe Hypertriglyceridemia: A Randomized Clinical Trial.
Mozaffarian D; Maki KC; Bays HE; Aguilera F; Gould G; Hegele RA; Moriarty PM; Robinson JG; Shi P; Tur JF; Lapointe JF; Aziz S; Lemieux P;
JAMA Netw Open; 2022 Jan; 5(1):e2141898. PubMed ID: 34989797
[TBL] [Abstract][Full Text] [Related]
13. A novel, multi-ingredient supplement to manage elevated blood lipids in patients with no evidence of cardiovascular disease: a pilot study.
Hobbs T; Caso R; McMahon D; Nymark M
Altern Ther Health Med; 2014; 20(5):18-23. PubMed ID: 25141367
[TBL] [Abstract][Full Text] [Related]
14. Effects of a new fish oil concentrate on plasma lipids and lipoproteins in patients with hypertriglyceridaemia.
Mackness MI; Bhatnagar D; Durrington PN; Prais H; Haynes B; Morgan J; Borthwick L
Eur J Clin Nutr; 1994 Dec; 48(12):859-65. PubMed ID: 7889894
[TBL] [Abstract][Full Text] [Related]
15. Effects of 12-week supplementation of marine Omega-3 PUFA-based formulation Omega3Q10 in older adults with prehypertension and/or elevated blood cholesterol.
Shen T; Xing G; Zhu J; Zhang S; Cai Y; Li D; Xu G; Xing E; Rao J; Shi R
Lipids Health Dis; 2017 Dec; 16(1):253. PubMed ID: 29282085
[TBL] [Abstract][Full Text] [Related]
16. A highly bioavailable omega-3 free fatty acid formulation improves the cardiovascular risk profile in high-risk, statin-treated patients with residual hypertriglyceridemia (the ESPRIT trial).
Maki KC; Orloff DG; Nicholls SJ; Dunbar RL; Roth EM; Curcio D; Johnson J; Kling D; Davidson MH
Clin Ther; 2013 Sep; 35(9):1400-11.e1-3. PubMed ID: 23998969
[TBL] [Abstract][Full Text] [Related]
17. Fish-oil supplementation alters numbers of circulating endothelial progenitor cells and microparticles independently of eNOS genotype.
Wu SY; Mayneris-Perxachs J; Lovegrove JA; Todd S; Yaqoob P
Am J Clin Nutr; 2014 Nov; 100(5):1232-43. PubMed ID: 25332321
[TBL] [Abstract][Full Text] [Related]
18. Effects of adding prescription omega-3 acid ethyl esters to simvastatin (20 mg/day) on lipids and lipoprotein particles in men and women with mixed dyslipidemia.
Maki KC; McKenney JM; Reeves MS; Lubin BC; Dicklin MR
Am J Cardiol; 2008 Aug; 102(4):429-33. PubMed ID: 18678300
[TBL] [Abstract][Full Text] [Related]
19. Docosahexaenoic acid supplementation decreases remnant-like particle-cholesterol and increases the (n-3) index in hypertriglyceridemic men.
Kelley DS; Siegel D; Vemuri M; Chung GH; Mackey BE
J Nutr; 2008 Jan; 138(1):30-5. PubMed ID: 18156400
[TBL] [Abstract][Full Text] [Related]
20. The benefits of ω-3 supplementation depend on adiponectin basal level and adiponectin increase after the supplementation: A randomized clinical trial.
Barbosa MM; Melo AL; Damasceno NR
Nutrition; 2017 Feb; 34():7-13. PubMed ID: 28063515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
